HOOKIPA Pharma Inc. (HOOK) News

HOOKIPA Pharma Inc. (HOOK): $1.57

-0.05 (-3.09%)

POWR Rating

Component Grades













Filter HOOK News Items

HOOK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HOOK News Highlights

  • 500 - Internal server error
  • Over the past 19 days, the trend for HOOK's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest HOOK News From Around the Web

Below are the latest news stories about HOOKIPA Pharma Inc that investors may wish to consider to help them evaluate HOOK as an investment opportunity.

HOOKIPA nears five-month low as SVB Leerink expects near-term pressure

Photo by tolgart/iStock via Getty Images Having lost more than a fifth of its value yesterday, HOOKIPA Pharma ([[HOOK]] -16.8%) is continuing the slide in reaction to the company’s updated data from the Phase 1/2 study for HB-200 in the treatment of advanced Human Papillomavirus 16-positive (HPV16+) cancers. The company evaluated...

Seeking Alpha | June 8, 2021

HOOKIPA Pharma slumps on Phase 1/2 data for lead cancer therapies

HOOKIPA Pharma ([[HOOK]] -7.1%) has sharply today after announcing an abstract that includes data for its lead assets HB-201 and HB-202 in advanced Human Papillomavirus 16-positive (HPV16+) cancers.The abstract will be part of an oral presentation scheduled for June 07 at the upcoming 2021 American Society of Clinical Oncology ((ASCO)) Annual Meeting.The...

Seeking Alpha | May 20, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6053 seconds.